At the news
? NEUTRALIMPACT 2/10 8-K filed Jun 10, 2026 at 16:15 ET
Abeona Therapeutics filed an 8-K furnishing an updated investor presentation (Exhibit 99.1) under Item 7.01 for use in meetings with investors and analysts. No material financial data, guidance updates, or business developments were disclosed, this is a routine disclosure of a corporate presentation used for investor relations.
- Filed an 8-K on June 10, 2026 furnishing an updated investor presentation under Item 7.01.
- The presentation is dated June 10, 2026 and is attached as Exhibit 99.1.
- No financial results, guidance, material agreements, or operational updates were disclosed.
- The filing is a routine Regulation FD disclosure for use in investor meetings.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access